This consolidation is unofficial and is for reference only.

For the official version of the regulations, consult the original documents on file with the Registry of Regulations , or refer to the Royal Gazette

Part II .

Regulations are amended frequently.

Please check the list of Regulations by Act to see if there are any recent amendments to these regulations filed with the Registry that are not yet included in this consolidation.

Although every effort has been made to ensure the accuracy of this electronic version, the Registry of Regulations assumes no responsibility for any discrepancies that may have resulted from reformatting.

This electronic version is copyright © 2011, Province of Nova Scotia , all rights reserved. It is for your personal use and may not be copied for the purposes of resale in this or any other form.

Drug Information System Prescription Monitoring Regulations

made under

Section 27 of the

Prescription Monitoring Act

S.N.S. 2004, c. 32

O.I.C. 2013-188 (June 4, 2013, effective July 1, 2013), N.S. Reg. 216/2013

Interpretation

Citation

1 These regulations may be cited as the Drug Information System Prescription Monitoring

Regulations .

Application of regulations

2 These regulations apply to every pharmacy and dispensing physician that uses the Drug

Information System.

Definitions

(1) In these regulations,

“Act” means the Prescription Monitoring Act ;

“dispensing physician” means a medical practitioner who dispenses, compounds or

administers drugs or medicines in the course of their practice of medicine under the

Medical Act ;

“Drug Information System” means the Drug Information System that is part of the

electronic health record and is

(

i) used by a pharmacy, a dispensing physician or authorized staff of a

pharmacy or a dispensing physician to record information about any drug

dispensed to a patient, and

(ii) used by the Department of Health and Wellness to provide information

to the Program about monitored drugs that are dispensed by pharmacies

and dispensing physicians;

“electronic health record” means the electronic health record as defined in the

Personal Health Information Regulations made under the Personal Health

Information Act ;

“pharmacy” means a pharmacy, including a hospital pharmacy, both as defined in

the Pharmacy Act ;

“prescription” means an authorization from a prescriber to dispense a monitored

drug;

“registrant” means a prescriber, pharmacist or pharmacy that is registered with the

Program.

(2) The following terms defined in the Act are further defined for the purposes of the

Act and these regulations:

“pharmacist” includes a certified dispenser as defined in the Pharmacy Act ;

“prescriber” does not include a veterinarian;

“resident” includes a person who is not a resident and to whom a monitored drug is

dispensed in the Province.

Designation of monitored drugs

4 Any drug that is a controlled drug under the Controlled Drugs and Substances Act

(Canada) and is listed in the Schedules to the Controlled Drugs and Substances Act

(Canada) or any successor legislation is designated as being subject to the Program.

Registration

Who must register with Program

(1) A prescriber who prescribes monitored drugs to residents must register with the

Program before their prescriptions for monitored drugs can be dispensed by a

pharmacy in the Province.

(2) A pharmacist, dispensing physician or pharmacy that dispenses monitored drugs to

residents must register with the Program.

Applying for registration

(1) An application for registration must be submitted to the Administrator.

(2) An applicant for registration must provide the Administrator with all the information

required by the Board and in a manner determined by the Board.

(3) An application for registration must be made in electronic or paper form, as

determined by the Board.

Notifying Administrator of changes to registrant’s information

(1) The licensing authority of a registrant must immediately notify the Administrator

when the registrant’s prescribing or dispensing privileges are restricted in any way.

(2) A registrant must notify the Administrator in writing of a change in their street or

mailing address at least 10 business days before the change of address comes into

effect.

(3) A pharmacy that closes must notify the Administrator in writing at least 10 business

days before the date of closure.

(4) A pharmacy that changes ownership must notify the Administrator in writing at least

10 business days before the date the change of ownership takes effect and must

reapply for registration with the Program.

Registrant’s forms and records required under Program

8 The Administrator must inform a registrant about what forms and records they are required

to keep under the Program.

Registrant in good standing with licensing authority

9 A registrant must be in good standing with their licensing authority.

Monitored Drugs

Form and manner of prescribing monitored drugs

10 A prescriber must not prescribe a monitored drug except in the manner approved by the

Board.

Monitored drugs used in office of prescriber

11 A prescriber who obtains a monitored drug from a pharmacy for use in their office must

order the monitored drug in the manner approved by the Board.

Form and manner of dispensing or releasing monitored drugs

12 A monitored drug must not be dispensed or released except in the manner approved by the

Board.

Manner of providing information about monitored drugs

13 Information, consultation and assistance respecting monitored drugs that is to be provided

by the Administrator under clause 12(2)(

g) of the Act must be provided in the manner

determined by the Board.

Program Information

Information provided to Administrator

(1) Information provided to the Administrator under

Section 18 of the Act must be

provided within the time specified by the Administrator.

(2) A registrant must provide any information required to be provided to the

Administrator in electronic or paper form, as determined by the Board.

Information not to be provided to Administrator

15 If a complaint has been initiated with a licensing authority under their regulating statute,

the licensing authority or the registrar or any other employee of the licensing authority

must not give the Administrator any of the following:

(

a) information about the complaint or the complainant, until the complaints and

disciplinary process under their regulating statute has ended;

(

b) the complainant’s name, at any time.

Retention of information collected under Program

16 The Administrator must keep all information collected under the Program about

registrants and residents in the manner determined by the Board.

Information released by Administrator

17 Information that may be released by the Administrator under subclause 12(2)(e)(iii) or

Section 20 of the Act must be released in the manner determined by the Board.

Information exchanged between prescribers and pharmacists

18 Prescribers and pharmacists may exchange information about a resident that is released by

the Administrator under subclause 12(2)(e)(iii) or

Section 20 of the Act.

Board and Committees

Expenses reimbursed for attendance at Board, committee or subcommittee meeting

19 For the purpose of

Section 10 of the Act, travel and meal expenses incurred in attending

Board, committee or subcommittee meetings are eligible for reimbursement in accordance with the rate paid to public servants of the Province, including, if applicable, a rate per kilometre for any distance driven.